Jackson Square Capital LLC Has $823,000 Stock Holdings in Synopsys, Inc. $SNPS

Jackson Square Capital LLC decreased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 68.9% in the third quarter, Holdings Channel reports. The firm owned 1,668 shares of the semiconductor company’s stock after selling 3,702 shares during the quarter. Jackson Square Capital LLC’s holdings in Synopsys were worth $823,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of SNPS. Saudi Central Bank bought a new position in shares of Synopsys during the 1st quarter worth approximately $26,000. Independence Bank of Kentucky raised its stake in Synopsys by 120.0% during the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 30 shares in the last quarter. Princeton Global Asset Management LLC lifted its holdings in shares of Synopsys by 481.8% during the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock valued at $33,000 after acquiring an additional 53 shares during the period. WPG Advisers LLC acquired a new stake in shares of Synopsys in the 1st quarter valued at $34,000. Finally, AlphaQuest LLC grew its holdings in shares of Synopsys by 423.1% in the 2nd quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 55 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: KeyCorp reiterated bullish coverage and published multi‑year EPS projections and a $600 price target, which supports upside expectations for SNPS and likely helped buying interest. KeyCorp estimates and MarketBeat summary
• Neutral Sentiment: Zacks and other outlets note elevated investor attention in SNPS; increased retail/institutional focus can amplify moves in either direction but does not by itself change fundamentals. Zacks: Investor Attention
• Neutral Sentiment: MarketWatch flagged that SNPS underperformed peers on a relative basis despite daily gains — a reminder that sector rotation and peer performance are constraining factors. MarketWatch: Relative Performance
• Negative Sentiment: Multiple securities‑fraud class‑action notices and law‑firm solicitations have been filed or distributed, alleging material misstatements for purchases made between Dec. 4, 2024 and Sept. 9, 2025; the widely publicized Dec. 30, 2025 lead‑plaintiff deadline increases headline risk and potential legal exposure. GlobeNewswire: Class Action Filed
• Negative Sentiment: Several plaintiff firms (Rosen, Levi & Korsinsky, Faruqi & Faruqi, Bleichmar Fonti & Auld, Schall, Gross, etc.) are soliciting lead‑plaintiff applications — this broad outreach typically precedes contested litigation phases that can drive volatility and potentially settlement costs or reputational damage. Example notice: Rosen Law Firm: Final Deadline Notice

Insider Buying and Selling

In other Synopsys news, CAO Sudhindra Kankanwadi sold 9,873 shares of the business’s stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the completion of the sale, the chief accounting officer directly owned 20,520 shares of the company’s stock, valued at approximately $10,278,468. The trade was a 32.48% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.62% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on SNPS. Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a report on Wednesday, October 8th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and dropped their price objective for the stock from $525.00 to $500.00 in a report on Monday, December 8th. Citigroup initiated coverage on Synopsys in a report on Monday, November 24th. They issued a “buy” rating and a $580.00 target price on the stock. BNP Paribas began coverage on Synopsys in a research report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target on the stock. Finally, Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Eleven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $562.13.

Synopsys Price Performance

SNPS opened at $463.73 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The stock has a market capitalization of $86.14 billion, a P/E ratio of 58.04, a price-to-earnings-growth ratio of 3.81 and a beta of 1.16. The company’s 50 day simple moving average is $434.19 and its 200-day simple moving average is $503.73. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business’s revenue for the quarter was up 37.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Sell-side analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.